Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants

The purpose of this study is to compare the effects and complications of pharmacologic closure of patent ductus arteriosus (PDA) by intravenous indomethacin or oral ibuprofen in neonates weighing <1500 g at birth [very low birth weight (VLBW) infants]. Methods: This is a retrospective study of in...

Full description

Saved in:
Bibliographic Details
Main Authors: Cheng Han Lee, Hsiao-Neng Chen, Long-Yen Tsao, Chien-Chou Hsiao, Meng-Luen Lee
Format: Article
Language:English
Published: Elsevier 2012-12-01
Series:Pediatrics and Neonatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957212001428
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849324593673666560
author Cheng Han Lee
Hsiao-Neng Chen
Long-Yen Tsao
Chien-Chou Hsiao
Meng-Luen Lee
author_facet Cheng Han Lee
Hsiao-Neng Chen
Long-Yen Tsao
Chien-Chou Hsiao
Meng-Luen Lee
author_sort Cheng Han Lee
collection DOAJ
description The purpose of this study is to compare the effects and complications of pharmacologic closure of patent ductus arteriosus (PDA) by intravenous indomethacin or oral ibuprofen in neonates weighing <1500 g at birth [very low birth weight (VLBW) infants]. Methods: This is a retrospective study of infants treated with intravenous indomethacin (0.2 mg/kg initially followed by two doses at 24-hour intervals) or oral ibuprofen (10 mg/kg initially followed an interval of 24 hours by two doses of 5 mg/kg) for symptomatic PDA in a neonatal intensive care unit at a medical center in Taiwan during the period of January 2005 to December 2010. Results: A total of 88 infants received indomethacin and 52 received oral ibuprofen. Among the survivors, the closure rate without surgical ductal ligation was 70.5% (62/88) in the indomethacin group and 61.5% (32/52) in the ibuprofen group (p = 0.342). The incidence rates of oliguria and elevated serum creatinine were significantly lower in the ibuprofen group (p =0.002 and p =0.022, respectively). There was no significant difference in incidence of upper gastrointestinal hemorrhage or necrotizing enterocolitis between the ibuprofen and indomethacin groups (17.3% versus 23.9%; 3.8% versus 11.3%). Conclusion: In infants with VLBW, oral ibuprofen is as effective as intravenous indomethacin for closure of PDA and is associated with significantly fewer cases of necrotizing enterocolitis among infants with birth body weights <1250 g and significantly lower rates of elevated creatinine levels among neonates with birth body weights ranging from 1000 to 1500 g.
format Article
id doaj-art-0a74a4e380d540bcbc7adf8981b391d6
institution Kabale University
issn 1875-9572
language English
publishDate 2012-12-01
publisher Elsevier
record_format Article
series Pediatrics and Neonatology
spelling doaj-art-0a74a4e380d540bcbc7adf8981b391d62025-08-20T03:48:41ZengElsevierPediatrics and Neonatology1875-95722012-12-0153634635310.1016/j.pedneo.2012.08.011Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight InfantsCheng Han Lee0Hsiao-Neng Chen1Long-Yen Tsao2Chien-Chou Hsiao3Meng-Luen Lee4Division of Neonatal Medicine and Pediatric Cardiology, Department of Pediatrics, Changhua Christian Hospital, Changhua, TaiwanDivision of Neonatal Medicine and Pediatric Cardiology, Department of Pediatrics, Changhua Christian Hospital, Changhua, TaiwanDivision of Neonatal Medicine and Pediatric Cardiology, Department of Pediatrics, Changhua Christian Hospital, Changhua, TaiwanDivision of Neonatal Medicine and Pediatric Cardiology, Department of Pediatrics, Changhua Christian Hospital, Changhua, TaiwanDivision of Neonatal Medicine and Pediatric Cardiology, Department of Pediatrics, Changhua Christian Hospital, Changhua, TaiwanThe purpose of this study is to compare the effects and complications of pharmacologic closure of patent ductus arteriosus (PDA) by intravenous indomethacin or oral ibuprofen in neonates weighing <1500 g at birth [very low birth weight (VLBW) infants]. Methods: This is a retrospective study of infants treated with intravenous indomethacin (0.2 mg/kg initially followed by two doses at 24-hour intervals) or oral ibuprofen (10 mg/kg initially followed an interval of 24 hours by two doses of 5 mg/kg) for symptomatic PDA in a neonatal intensive care unit at a medical center in Taiwan during the period of January 2005 to December 2010. Results: A total of 88 infants received indomethacin and 52 received oral ibuprofen. Among the survivors, the closure rate without surgical ductal ligation was 70.5% (62/88) in the indomethacin group and 61.5% (32/52) in the ibuprofen group (p = 0.342). The incidence rates of oliguria and elevated serum creatinine were significantly lower in the ibuprofen group (p =0.002 and p =0.022, respectively). There was no significant difference in incidence of upper gastrointestinal hemorrhage or necrotizing enterocolitis between the ibuprofen and indomethacin groups (17.3% versus 23.9%; 3.8% versus 11.3%). Conclusion: In infants with VLBW, oral ibuprofen is as effective as intravenous indomethacin for closure of PDA and is associated with significantly fewer cases of necrotizing enterocolitis among infants with birth body weights <1250 g and significantly lower rates of elevated creatinine levels among neonates with birth body weights ranging from 1000 to 1500 g.http://www.sciencedirect.com/science/article/pii/S1875957212001428oral ibuprofenindomethacinpatent ductus arteriosusvery low birth weight infants
spellingShingle Cheng Han Lee
Hsiao-Neng Chen
Long-Yen Tsao
Chien-Chou Hsiao
Meng-Luen Lee
Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
Pediatrics and Neonatology
oral ibuprofen
indomethacin
patent ductus arteriosus
very low birth weight infants
title Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
title_full Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
title_fullStr Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
title_full_unstemmed Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
title_short Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
title_sort oral ibuprofen versus intravenous indomethacin for closure of patent ductus arteriosus in very low birth weight infants
topic oral ibuprofen
indomethacin
patent ductus arteriosus
very low birth weight infants
url http://www.sciencedirect.com/science/article/pii/S1875957212001428
work_keys_str_mv AT chenghanlee oralibuprofenversusintravenousindomethacinforclosureofpatentductusarteriosusinverylowbirthweightinfants
AT hsiaonengchen oralibuprofenversusintravenousindomethacinforclosureofpatentductusarteriosusinverylowbirthweightinfants
AT longyentsao oralibuprofenversusintravenousindomethacinforclosureofpatentductusarteriosusinverylowbirthweightinfants
AT chienchouhsiao oralibuprofenversusintravenousindomethacinforclosureofpatentductusarteriosusinverylowbirthweightinfants
AT mengluenlee oralibuprofenversusintravenousindomethacinforclosureofpatentductusarteriosusinverylowbirthweightinfants